Otros idiomas AptarGroup, Inc.

Acciones

ATR

US0383361039

Mercado cerrado - Nyse Otros sitios de cotización 22:00:02 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
143,3 ^USD	+2,25 %		+2,86 %	+15,94 %

26/04	Transcript : AptarGroup, Inc., Q1 2024 Earnings Call, Apr 26, 2024
25/04	Aumentan los beneficios ajustados y las ventas de AptarGroup en el 1T; fija las previsiones de beneficios por acción para el 2T	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

AptarGroup Q1 Adjusted Earnings, Sales Rise; Sets Q2 EPS Guidance	25/04
AptarGroup : Q1 Press Release Presentation	25/04
AptarGroup, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
AptarGroup: Q1 Earnings Snapshot	25/04
Earnings Flash (ATR) APTARGROUP Posts Q1 Revenue $915.4M, vs. Street Est of $890.9M	25/04
Earnings Flash (ATR) APTARGROUP Reports Q1 EPS $1.26, vs. Street Est of $1.15	25/04
Aptar Reports First Quarter 2024 Results	25/04
AptarGroup Keeps Quarterly Cash Dividend at $0.41 a Share, Payable May 16 to Holders of Record April 25	11/04
Aptar Declares Quarterly Dividend	11/04
AptarGroup, Inc. Declares Quarterly Dividend, Payable on May 16, 2024	11/04
Aptar Named a CDP Supplier Engagement Leader for the Fourth Consecutive Year	20/03
Aptar - Food Protection Enters Exclusive Partnership with Halopack to Launch Recyclable, Fiber-based Tray System in North America	15/03
Aptargroup Insider Sold Shares Worth $284,906, According to a Recent SEC Filing	12/03
Aptargroup Insider Sold Shares Worth $499,932, According to a Recent SEC Filing	12/03
Aptargroup Insider Sold Shares Worth $4,533,394, According to a Recent SEC Filing	05/03
Aptar Named One of Barron's 100 Most Sustainable U.S. Companies for the Sixth Consecutive Year	01/03
Aptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Sixth Consecutive Year	29/02
Tanda, CEO of Aptar: Inflation less of a concern in the pharmaceutical sector	12/02
Aptar Signs Enterprise Agreement with Biogen to Operate and Develop Digital Health Solutions	12/02
AptarGroup's Digital Health Business, Biogen to Develop Products for Neurological, Rare Diseases	09/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas AptarGroup, Inc.

Acciones

ATR

US0383361039

Otros idiomas

Filtros